Chloroquine
| Code | Size | Price |
|---|
| TAR-T8689-1mL | 1 mL * 10 mM (in DMSO) | £111.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
| TAR-T8689-100mg | 100mg | £114.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
| TAR-T8689-200mg | 200mg | £146.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
| TAR-T8689-500mg | 500mg | £222.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
Chloroquine is an autophagy and toll-like receptors (TLRs) inhibitor. Chloroquine is an antimalarial and anti-inflammatory agent widely used to treat malaria and rheumatoid arthritis. Chloroquine is highly effective in the control of SARS-CoV-2 (COVID-19) infection in vitro with EC50 of 1.13 μM.
Biological Applications:
Sotorasib is the first FDA-approved inhibitor for the treatment of KRASG12C-mutated non-small cell lung cancer (NSCLC). Subsequently, the FDA granted Breakthrough Therapy designation to Adagrasib, providing a potential treatment option for patients with KRASG12C-mutated NSCLC who have previously undergone systemic therapy.
KRASG12C is a specific submutation of KRAS, constituting approximately 44% of all KRAS mutations. It is most commonly found in adenocarcinomas of non-small cell lung cancer, followed by colorectal adenocarcinomas and pancreatic cancers. Globally, over 100,000 people are diagnosed with KRASG12C mutations annually. Sotorasib represents a novel discovery in cancer treatment. Preclinical and clinical studies indicate that cellular differentiation, molecular activation, and genetic mutations can contribute to intrinsic or acquired resistance to KRASG12C inhibitors, including ARS-1620, sotorasib, and adagrasib.
CAS:
54-05-7
Description:
Adagrasib (MRTX849) is a potent, selective and covalent KRASG12C inhibitor with potential antineoplastic activity. It selectively modifies mutant cysteine 12 in GDP-bound KRASG12C, and inhibits KRAS-dependent signaling.
Formula:
C18H26ClN3
Mechanism of Action:
Sotorasib and Adagrasib are selective KRASG12C inhibitors. The KRAS protein is a signaling GTPase that can switch between an active GTP-bound conformation and an inactive GDP-bound conformation. KRASG12C is a specific submutation of KRAS, where glycine at the 12th codon is replaced by cysteine. Both Sotorasib and Adagrasib covalently bind to the cysteine residue in the KRASG12C mutant, locking the KRAS protein in an inactive state. This disruption of downstream signaling pathways contributes to the anti-tumor effects, without affecting the wild-type KRAS.
KRAS can hydrolyze the γ-phosphate of GTP to convert it to GDP. The inactive and active states of KRAS are regulated by GAP and GEF, respectively. RTKs (Receptor Tyrosine Kinases) represent the second-largest class of cell surface receptors with diverse functions, including the promotion of KRAS activation and subsequent involvement in various downstream pathways, notably the RAF-MEK-ERK and PI3K-AKT-mTOR pathways. Unlike wild-type KRAS, which maintains a balance between inactive and activated states, the cysteine 12 (C12) mutation disrupts the GTPase activity of KRAS, locking it in the GTP-bound state.
In contrast, small molecule drugs like sotorasib (or adagrasib) can form a covalent bond with the C12 residue in the KRAS-G12C protein, resulting in KRAS being in an inactive state.
Molecular Weight:
319.88
Pathway:
Microbiology/Virology; Immunology/Inflammation; Proteases/Proteasome; Autophagy
Purity:
0.9998
Research Area:
NSCLC (Non-small-cell lung cancer); Adenocarcinoma; Rectal adenocarcinoma; Pancreatic cancer
SMILES:
CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12
Target:
SARS-CoV; TLR; HIV Protease; Antibiotic; Parasite; Autophagy
References
Wang J, Su Q, Wu Q, et al. Sanguinarine impairs lysosomal function and induces ROS-dependent mitophagy and apoptosis in human hepatocellular carcinoma cells. Archives of Pharmacal Research. 2021: 1-12.
Pan X, Li R, Guo H, et al. Dihydropyridine Calcium Channel Blockers Suppress the Transcription of PD-L1 by Inhibiting the Activation of STAT1. Frontiers in Pharmacology. 2021 Jan 13;11:539261. doi: 10.3389/fphar.2020.539261. eCollection 2020.
Su G, Yang W, Wang S, et al. SIRT1-autophagy axis inhibits excess iron-induced ferroptosis of foam cells and subsequently increases IL-1? and IL-18. Biochemical and Biophysical Research Communications. 2021, 561: 33-39.
Zhou Y, Li Q, Zheng J, et al. N-Glycosylation on Asn50 of SND1 Is Required for Glioma U87 Cell Proliferation and Metastasis. Journal of Immunology Research. 2022
Nicholson M W, Huang C Y, Wang J Y, et al. Cardio-and Neurotoxicity of Selected Anti-COVID-19 Drugs. Pharmaceuticals. 2022, 15(6): 765
Shan X, Jiang R, Gou D, et al.Identification of a diketopiperazine?based O?GlcNAc transferase inhibitor sensitizing hepatocellular carcinoma to CDK9 inhibition.The FEBS Journal.2023
Wang W, Li S, Xu X, et al. Danshensu alleviates pseudo-typed SARS-CoV-2 induced mouse acute lung inflammation. Acta Pharmacologica Sinica. 2021: 1-10.
Xiang H, Wang R.Discovery of small-molecule inhibitors for the protein-protein interactions involving ATG5.Autophagy Reports.2023, 2(1): 2215617.
Chen J, Li J, Chen J, et al. Treatment of collagen-induced arthritis rat model by using Notch signalling inhibitor. Journal of Orthopaedic Translation. 2021, 28: 100-107.
Wang F, Xie M, Chen P, et al. Homoharringtonine combined with cladribine and aclarubicin (HCA) in acute myeloid leukemia: A new regimen of conventional drugs and its mechanism. Oxidative Medicine and Cellular Longevity. 2022
Dai H, Wang J, Huang Z, et al. LncRNA OIP5-AS1 Promotes the Autophagy-Related Imatinib Resistance in Chronic Myeloid Leukemia Cells by Regulating miR-30e-5p/ATG12 Axis. Technology in cancer research & treatment. 2021, 20: 15330338211052150.
Xu C, Zhao W, Huang X, et al. TORC2/3-mediated DUSP1 upregulation is essential for human decidualization. Reproduction. 2021, 1(aop).
Xiao Q, Lei L, Ren J, et al. Mutant NPM1-Regulated FTO-Mediated m6A Demethylation Promotes Leukemic Cell Survival via PDGFRB/ERK Signaling Axis. Frontiers in Oncology. 2022.12
Wang M, Xu Y, Zhang Y, et al. Deciphering the autophagy regulatory network via single-cell transcriptome analysis reveals a requirement for autophagy homeostasis in spermatogenesis. Theranostic. 2021 Mar 5;11(10):5010-5027. doi: 10.7150/thno.55645. eCollection 2021.
Cao P, Wang Y, Zhang C, et al.Quercetin ameliorates non-alcoholic fatty liver disease (NAFLD) via the promotion of AMPK-mediated hepatic mitophagy.The Journal of Nutritional Biochemistry.2023: 109414.
Zhang W, Pan X, Xu Y, et al.Mevalonate improves anti-PD-1/PD-L1 efficacy by stabilizing CD274 mRNA.Acta Pharmaceutica Sinica B.2023
Said A, et al. Chloroquine promotes IL-17 production by CD4+ T cells via p38-dependent IL-23 release by monocyte-derived Langerhans-like cells. J Immunol. 2014 Dec 15;193(12):6135-43.
Zhang M, Jia X, Cheng C, et al.Capsaicin functions as a selective degrader of STAT3 to enhance host resistance to viral infection.Acta Pharmacologica Sinica.2023: 1-12.
Pan X, Li R, Guo H, et al. Dihydropyridine Calcium Channel Blockers Suppress the Transcription of PD-L1 by Inhibiting the Activation of STAT1[J]. Frontiers in Pharmacology. 2021, 11: 2233.
Su G, Yang W, Wang S, et al. SIRT1-autophagy axis inhibits excess iron-induced ferroptosis of foam cells and subsequently increases IL-1? and IL-18[J]. Biochemical and Biophysical Research Communications. 2021, 561: 33-39.
Han S, Zhang H, Liu X, et al.Enhanced autophagy reversed aflatoxin B1-induced decrease in lactate secretion of dairy goat Sertoli cells.Ecotoxicology and Environmental Safety.2023, 259: 115063.
Mohamed FE, et al. Effect of toll-like receptor 7 and 9 targeted therapy to prevent the development of hepatocellular carcinoma. Liver Int. 2014 Jul 2. doi: 10.1111/liv.12626.
Zhu X, Huang N, Ji Y, et al.Brusatol induces ferroptosis in oesophageal squamous cell carcinoma by repressing GSH synthesis and increasing the labile iron pool via inhibition of the NRF2 pathway.Biomedicine & Pharmacotherapy.2023, 167: 115567.
Zhao L, Zhang W, Luan F, et al.Butein suppresses PD-L1 expression via downregulating STAT1 in non-small cell lung cancer.Biomedicine & Pharmacotherapy.2023, 157: 114030.
Ding L, Chen X, Zhang W, et al.Canagliflozin primes antitumor immunity by triggering PD-L1 degradation in endocytic recycling.The Journal of Clinical Investigation.2023, 133(1).
Tuomela J, et al. Chloroquine has tumor-inhibitory and tumor-promoting effects in triple-negative breast cancer. Oncol Lett. 2013 Dec;6(6):1665-1672.
Liu X, Fang Y, Lv X, et al.Deubiquitinase OTUD6A in macrophages promotes intestinal inflammation and colitis via deubiquitination of NLRP3.Cell Death & Differentiation.2023: 1-15.
Chen J, Li J, Chen J, et al. Treatment of collagen-induced arthritis rat model by using Notch signalling inhibitor[J]. Journal of Orthopaedic Translation. 2021, 28: 100-107.
Xu C, Zhao W, Huang X, et al. TORC2/3-mediated DUSP1 upregulation is essential for human decidualization[J]. Reproduction. 2021, 1(aop).
Wang M, Xu Y, Zhang Y, et al. Deciphering the autophagy regulatory network via single-cell transcriptome analysis reveals a requirement for autophagy homeostasis in spermatogenesis[J]. Theranostic. 2021, 11(10): 5010.
Yan C, Zheng L, Jiang S, et al.Exhaustion-associated cholesterol deficiency dampens the cytotoxic arm of antitumor immunity.Cancer Cell.2023
Yu Q, Li C, Niu Q, et al.Hepatic COX1 loss leads to impaired autophagic flux and exacerbates nonalcoholic steatohepatitis.Acta Pharmaceutica Sinica B.2023
Jiao J, Ruan L, Cheng C, et al.Paired protein kinases PRKCI-RIPK2 promote pancreatic cancer growth and metastasis via enhancing NF-?B/JNK/ERK phosphorylation.Molecular Medicine.2023, 29(1): 1-17.
Lei S, Chen C, Han F, et al.AMER1 deficiency promotes the distant metastasis of colorectal cancer by inhibiting SLC7A11-and FTL-mediated ferroptosis.Cell Reports.2023, 42(9).
Xiang H, Liu R, Zhang X, et al.Discovery of Small-Molecule Autophagy Inhibitors by Disrupting the Protein?Protein Interactions Involving Autophagy-Related 5.Journal of Medicinal Chemistry.2023